Karus Therapeutics presenting at BioTrinity 2015

Simon Kerry, CEO of Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, will be attending and presenting at BioTrinity 2015, 11-13 May 2015 in Oxford, UK. For more information on Karus’s presentations or for media enquiries, please contact karus@instinctif.com.

Karus Therapeutics presenting at AACR Annual Meeting 2015

Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has announced that it will be giving two poster presentations at the AACR Annual Meeting in Philadelphia, 18–22 April 2015. Stephen Shuttleworth, Karus’s CSO, will present the posters describing the company’s pre-clinical cancer programmes.  The title of […]